Report Categories
View AllRecent Articles
View All
Is AXT AXTI stock a strategic buy Q4 2025 Better Than Expected
INVESCO IVR Stock Price Movement Behavior INVESCO MORTGAGE CAPITAL posts tiny 06 EPS miss
Mereo MREO Industry Ranking Mereo BioPharma posts 237 EPS beat steady Q4 revenue
Is Chiron XRN stock a smart buy at current levels In Focus 20260422
AerCap AER EPS smashes forecasts with 429 beat marking major quarterly outperformance
Marathon Petroleum Corp MPC
International Business Machines Corporation IBM
Whats Next for Real Asset RAAQU at 1375 20260515
ADP Report Shows Private Sector Added 109000 Jobs in April Exceeding Expectations
Forum FRMM Q1 2026 Results Miss Estimates EPS 358 vs 022
Atlantic ATLN Stock Analysis 775 Loss Key Levels 20260518
Grupo SUPV Falls 625 Watching 698 Support 20260519
Paloma PALOU Trading at 1010 Key Decision Point 20260519
Novartis Upgrades FullYear Sales and Profit Outlook
Samir Arora Rejects Jefferies Claim SIPs Not the Cause of Rupee Weakness
Endurance Technologies IPO Opens Company Eyes Rs 1162 Crore Through Public Issue
US Productivity Growth Decelerates in Q4 as Labor Costs Rise
Pokemon Card Boom Fuels MultiMillion Dollar Sales as Nostalgia and Speculation Collide
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Industry Minister
DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline
GROY Q1 2026 Earnings Slight EPS Miss Amidst Quiet Quarter
CTMX Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues
NVS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher
Bowman Consulting Group Ltd BWMN Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Challenging Quarter
AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance
United Therapeutics UTHR Slips 152 as Biotech Sector Faces Headwinds Support and Resistance in Focus
Calamos Global Dynamic Income Fund CHW Rallies 172 Approaching Key Resistance
Proficient Auto Logistics PAL Holds Near Support After Slight Decline
BHFAL Pushes Higher as Yield Appeal Holds Steady
Inovio Pharmaceuticals INO Holds Near Support Amid Slight Decline